The rapid ascent of GLP-1 weight-loss medications is reshaping more than just healthcare; it is creating a new, specific pipeline of demand for the beauty and wellness industry. Ulta Beauty CEO Kecia Steelman recently highlighted how the side effects and physical changes associated with these drugs are driving customers toward a new set of skincare and haircare solutions.
In an interview with Yahoo Finance’s Opening Bid, Steelman noted that the “GLP-1 craze” has led to a surge in interest for products that address rapid weight loss. Specifically, she pointed to the need for moisture and elasticity support for the skin, as well as targeted treatments for hair thinning, which can occur during significant weight fluctuations.
This shift is part of a broader economic ripple effect. As medications like Wegovy and Ozempic gain mainstream adoption, the “after-care” market—ranging from high-end serums to professional tailoring—is beginning to scale alongside the pharmaceuticals.
The Biological Driver: Hair Loss and Skin Elasticity
The demand for specific beauty products is not merely a trend but a response to clinical side effects. Steelman emphasized that “Hair loss with GLP-1s is real, and products that can help with that,” while likewise noting that “skin elasticity, when you’re losing weight really rapidly, you know, the skin elasticity is something that you’ve got to get moisture into.”
Medical data supports these observations. In clinical trials for Wegovy, hair loss was reported as a side effect in 3% of participants. While this percentage may seem low, the sheer volume of users means millions of people are experiencing these changes simultaneously.
Steelman observed a significant “crossover” in consumer behavior, noting that GLP-1 users are seeking the same types of products as those with aging skin. Both demographics are focused on what she described as maintaining “the longevity of the look,” shifting the focus of the beauty aisle toward preventative and restorative care.
A Multi-Industry Economic Ripple Effect
The influence of GLP-1 drugs extends far beyond the skincare aisle. The phenomenon known as “Ozempic face”—a sunken appearance caused by the rapid loss of subcutaneous fat in the cheeks—has created a windfall for the medical aesthetics industry. The CEO of Swiss pharmaceutical giant Galderma previously indicated a strong rise in demand for facial fillers to counteract this specific look.
The impact is even visible in the fashion sector. Tailors in New York City’s Wall Street district have reported a surge in clients returning with entire professional wardrobes that need to be significantly taken in to fit their new frames.
The scale of this shift is underscored by the sheer number of users. An EY consumer products expert estimated in 2025 that approximately 10% of the U.S. Population is currently utilizing some form of weight-loss medication.
Ulta Beauty’s Market Position
Ulta has positioned itself to capture this shifting demand by integrating wellness and specialized care into its retail mix. The company’s financial performance reflects a period of strong growth, with 2025 annual sales reaching approximately $12.39 billion, an increase of 11.8% over the previous year.
| Metric | Value/Change |
|---|---|
| Annual Sales | $12.39 Billion |
| Year-over-Year Growth | +11.8% |
| Core Category Contribution* | 43% of Total Sales |
| Stock Price Trend (1 Year) | ~50% Increase |
*Includes Skincare, Wellness, and Hair Care.
What This Means for the Future of Beauty
As the GLP-1 market matures, the beauty industry is moving away from generic “anti-aging” marketing toward “solution-based” skincare. The focus is shifting toward biological needs—such as moisture retention and follicle support—rather than just cosmetic improvement.
While Ulta has not disclosed the specific brands or product lines seeing the highest growth, the overall trend suggests a move toward “medical-grade” or “clinical” beauty products that can be sold in a retail environment. This hybrid approach allows consumers to manage the side effects of their medical treatments through accessible over-the-counter wellness products.
Disclaimer: This article is for informational purposes only and does not constitute medical or financial advice. Please consult a healthcare provider regarding the side effects of GLP-1 medications.
The next major indicator of this trend’s impact will likely appear in upcoming quarterly earnings reports and product launch cycles, as beauty brands specifically formulate “GLP-1 friendly” skincare and hair recovery lines to meet this verified consumer need.
We want to hear from you. Have you noticed a shift in the beauty products you’re using or seeing in stores? Share your thoughts in the comments below.
